SARS-CoV-2 Spike receptor binding domain, RBD (371-394) – 0.5 mg

Overview

The SARS-CoV-2 Spike receptor binding domain (RBD) peptide, specifically residues 371-394, is a crucial component studied for its role in virus-host interactions. This peptide sequence, identified from the spike protein of SARS-CoV-2 (RefSeq YP_009724390.1), is instrumental in research focused on understanding viral entry mechanisms and developing targeted therapeutics. You can shop now to add this essential reagent to your lab’s inventory.

Key Features

• High purity for reliable results in research applications.
• Offers insights into the binding affinity of SARS-CoV-2 to the ACE2 receptor.
• Suitable for various research applications including immunology, virology, and vaccine development.
• Provided in a convenient 0.5 mg quantity for ease of use in experiments.
• Backed by our commitment to quality and performance in peptide synthesis.

Specifications

FAQ

What is the significance of the RBD in SARS-CoV-2 research?

The receptor binding domain (RBD) is essential for the virus’s ability to attach to host cells. Understanding this interaction aids in the development of vaccines and therapeutics.

How should I store this peptide?

Store the SARS-CoV-2 RBD peptide at -20°C to maintain its stability. Avoid repeated freeze-thaw cycles to preserve its integrity.

Can this peptide be used in diagnostic assays?

Yes, the RBD peptide is suitable for various diagnostic assays, especially those focusing on antibody detection and binding studies.

To enhance your research on viral proteins, consider exploring our PKG Substrate and the Autocamtide-2 for your experimental needs. Make your purchase today and contribute to groundbreaking studies in the field!

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled